SCHEMBL2580333

SCHEMBL2580333

CC(C)(C)OC(=O)NC(=O)CC[C@@H](N)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 2/20 0.44
GRM8 O00222 1/20 0.44
GRM6 O15303 1/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GSR P00390 1/20 0.44
CYP1A2 P05177 1/20 0.44
GRIK1 P39086 1/20 0.44
GRM5 P41594 1/20 0.44
GRIA1 P42261 1/20 0.44
GRIA2 P42262 1/20 0.44
GRIA3 P42263 1/20 0.44
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44
GRIA4 P48058 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIK2 Q13002 1/20 0.44
GRIK3 Q13003 1/20 0.44
GRIN2B Q13224 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954829 1.00 SLC1A1 (0.44) SLC1A1GRM8GRM6GRIN2DGRIN3B
SCHEMBL11016322 1.00 SLC1A1 (0.44) SLC1A1GRM8GRM6GRIN2DGRIN3B
SCHEMBL5548795 0.83 MEN1 (0.42) SLC1A1GRIK1GRIA2SLC1A3SLC1A2
SCHEMBL4533199 0.83 MEN1 (0.42) SLC1A1GRIK1GRIA2SLC1A3SLC1A2
SCHEMBL30397458 0.83 KMT2A (0.43) SLC1A1GRM8GRM6GRIN2DGRIN3B
SCHEMBL12254869 0.83 KMT2A (0.55) SLC1A1GRM8GRM6GRIN2DGRIN3B
SCHEMBL30684683 0.81 MEN1 (0.60) KMT2AMEN1GAANOD1
SCHEMBL21690090 0.79 SLC1A1 (0.43) SLC1A1GRM8GRM6GRIN2DGRIN3B
SCHEMBL19974086 0.79 MEN1 (0.36) KMT2AMEN1GAALTA4HAPLNR
SCHEMBL31562940 0.78 GSR (0.62) SLC1A1GRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed
EP-1899330-A1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT Boehringer Ingelheim International GmbH (DE) 2008-03-19 EP disclosed
WO-2007003536-A1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-11 WO disclosed
CN-1017436-B PEPTIDE CONTAINING IMMUNOEXCITANT PFIZER (US) 1992-07-15 CN disclosed
CN-86107931-A PEPTIDE CONTAINING IMMUNOEXCITANT 1987-07-01 CN disclosed